Skip to main content

Table 3 Ascites production from syngeneic BALB/C mice using various priming agents

From: Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses

Hybrid line

Isotype of Ig

1Priming agent

Total volume collected (ml)

Mouse number providing ascites/number injected

2Yield/mouse (ml)

3Antibody titer (OD @ 490 nm)

2C3

IgG1 (γ1, κ)

None (PBS)

None

0/4

None

4ND

  

Pristane

12

4/4

3

1.3

  

Phytol

1.6

1/4

1.6

1.1

  

PHIS-01

8

3/4

2.7

0.9

1H524

IgM (μ, κ)

None (PBS)

None

0/4

None

4ND

  

Pristane

16

4/4

4

0.8

  

Phytol

9.3

2/4

4.65

0.75

2B424

IgM (μ, κ)

None (PBS)

None

0/4

None

4ND

  

Pristane

15

3/4

5

1.15

  

Phytol

19

4/4

4.75

1.32

  1. 1 40 μg of each substance was used
  2. 2 Average volumes of ascites producing per number of mouse injected
  3. 3 Ascites after salt fractionation using 50% ammonium sulfate were tested by ELISA at 50 μg/ml [31].
  4. 4 Not detected; No significant antibody titer was detected.